aTYR PHARMA (ATYR) Other Non-Current Liabilities (2014 - 2016)

aTYR PHARMA (ATYR) has reported Other Non-Current Liabilities for 3 consecutive years, with $557000.0 the latest figure, recorded in Q1 2016.

• For the quarter ending Q1 2016, Other Non-Current Liabilities rose 46.58% year-over-year to $557000.0; the trailing twelve-month figure through Mar 2016 stood at $557000.0 (up 46.58% YoY), and the FY2015 full-year result was $571000.0, up 70.45% from the prior year.
• Other Non-Current Liabilities eased to $557000.0 in Q1 2016 per ATYR's latest filing, from $571000.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $588000.0 in Q2 2015 and bottomed at $335000.0 in Q4 2014.
• Historically, Other Non-Current Liabilities has averaged $502666.7 across 3 years, with a median of $564000.0 in 2015.
• The sharpest annual moves came in 2015 and 2016: Other Non-Current Liabilities soared 70.45% in 2015, then jumped 46.58% in 2016.
• Over 3 years, Other Non-Current Liabilities stood at $335000.0 in 2014, then jumped by 70.45% to $571000.0 in 2015, then retreated by 2.45% to $557000.0 in 2016.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $557000.0, $571000.0, and $585000.0 for Q1 2016, Q4 2015, and Q3 2015 respectively.